Onvansertib fumarateProduct ingredient for Onvansertib

Show full entry for Onvansertib
Name
Onvansertib fumarate
Drug Entry
Onvansertib

Onvansertib is under investigation in clinical trial NCT03303339 (Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).).

See full entry for Onvansertib
Accession Number
DBSALT003265
Structure
Synonyms
1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy) phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide fumarate salt / NMS-P937 fumarate / NMS-P937 fumarate salt / PCM-075 fumarate
UNII
HMP6CI6R6V
CAS Number
1263293-37-3
Not Available
Predicted Properties
Not Available